Kirkland & Ellis has advised Suzhou Ribo Life Science Co., Ltd. on its global offering and listing. O’Melveny & Myers has represented the joint sponsors CICC...
Ribo Life Science Completes HK$1.83 Billion Hong Kong IPO
Suzhou Ribo Life Science’s $40 Million Series E1 Financing Round
Kirkland & Ellis advised Suzhou Ribo Life Science Co., Ltd. on the transaction. Suzhou Ribo Life Science Co., Ltd. (Ribo), a clinical stage company developing innovative...


























